Drive to enable cross-border access to clinical trials across the EU

The European Forum for Good Clinical Practice (EFGCP) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) have launched an initiative to enable cross-border access to clinical trials for patients across the continent.

With no current European framework to define the conditions for cross border clinical trials, the project will map out the current state of each member state, detailing the logistical and financial support required as well as issues like accessing ongoing treatment for those patients involved.

It is hoped that the project will help bringing ground-breaking trials to patients in European Union (EU) countries which previously had no access and could revolutionize treatment options for those with rare diseases.